Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Molina Healthcare Inc
24.7% sales growth and 40.03% return on equity
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.
Molina Healthcare Inc’s sales growth this year is expected to be 16% and 17.3% for next year.
Year-on-year quarterly revenue growth grew by 16%, now sitting on 17.66B for the twelve trailing months.
Molina Healthcare Inc’s sales growth for the next quarter is 24.7%. The company’s growth estimates for the present quarter and the next is a negative 46.9% and 21.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.03%.
Volatility
Molina Healthcare Inc’s last day, last week, and last month’s average volatility was 0.43%, 2.76%, and 0.60%, respectively.
Molina Healthcare Inc’s last day, last week, and last month’s high and low average amplitude percentage was 3.35%, 4.40%, and 3.03%, respectively.
Molina Healthcare Inc’s Stock Yearly Top and Bottom Value
Molina Healthcare Inc’s stock is valued at $243.10 at 19:22 EST, under its 52-week high of $246.72 and way higher than its 52-week low of $102.85.
Molina Healthcare Inc’s Moving Average
Molina Healthcare Inc’s worth is way higher than its 50-day moving average of $210.05 and way above its 200-day moving average of $194.64.
2. Alexion Pharmaceuticals, Inc.
9.5% sales growth and 8.92% return on equity
Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products.
Alexion Pharmaceuticals, Inc.’s sales growth this year is expected to be 20.8% and 9.2% for next year.
Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 5.86B for the twelve trailing months.
Alexion Pharmaceuticals, Inc.’s sales growth for the next quarter is 9.5%. The company’s growth estimates for the present quarter and the next is a negative 5.5% and negative -3.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.92%.
Volatility
Alexion Pharmaceuticals, Inc.’s last day, last week, and last month’s average volatility was 1.03%, 0.14%, and 1.49%, respectively.
Alexion Pharmaceuticals, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 0.85%, 1.22%, and 1.47%, respectively.
Alexion Pharmaceuticals, Inc.’s Stock Yearly Top and Bottom Value
Alexion Pharmaceuticals, Inc.’s stock is valued at $157.35 at 19:22 EST, below its 52-week high of $160.03 and way higher than its 52-week low of $72.67.
Alexion Pharmaceuticals, Inc.’s Moving Average
Alexion Pharmaceuticals, Inc.’s value is way above its 50-day moving average of $140.79 and way above its 200-day moving average of $119.39.
3. Provident Bancorp, Inc.
14.8% sales growth and 5.45% return on equity
Provident Bancorp, Inc. operates as a holding company for The Provident Bank that provides various financial services to individuals and small businesses in the United States.
Provident Bancorp, Inc.’s sales growth this year is anticipated to be 23% and 4.4% for next year.
Year-on-year quarterly revenue growth grew by 25.6%, now sitting on 47.86M for the twelve trailing months.
Provident Bancorp, Inc.’s sales growth for the next quarter is 14.8%. The company’s growth estimates for the ongoing quarter and the next is 57.1% and 57.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.45%.
Volatility
Provident Bancorp, Inc.’s last day, last week, and last month’s average volatility was a negative 1.75%, a negative 0.42%, and a positive 0.49%, respectively.
Provident Bancorp, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.77%, 2.85%, and 3.93%, respectively.
Provident Bancorp, Inc.’s Stock Yearly Top and Bottom Value
Provident Bancorp, Inc.’s stock is valued at $11.97 at 19:22 EST, below its 52-week high of $12.55 and way above its 52-week low of $7.21.
Provident Bancorp, Inc.’s Moving Average
Provident Bancorp, Inc.’s value is higher than its 50-day moving average of $11.24 and way higher than its 200-day moving average of $8.88.
4. Euroseas Ltd.
7.1% sales growth and 9.93% return on equity
Euroseas Ltd.
Euroseas Ltd.’s sales growth this year is expected to be 31.6% and 17.2% for next year.
Year-on-year quarterly revenue growth grew by 19.7%, now sitting on 54.58M for the twelve trailing months.
Euroseas Ltd.’s sales growth for the next quarter is 7.1%. The company’s growth estimates for the present quarter and the next is 127.8% and 56.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.93%.
Volatility
Euroseas Ltd.’s last day, last week, and last month’s average volatility was 16.23%, 4.56%, and 0.95%, respectively.
Euroseas Ltd.’s last day, last week, and last month’s high and low average amplitude percentage was 16.78%, 9.61%, and 8.87%, respectively.
Euroseas Ltd.’s Stock Yearly Top and Bottom Value
Euroseas Ltd.’s stock is valued at $6.73 at 19:22 EST, under its 52-week high of $6.82 and way higher than its 52-week low of $1.23.
Euroseas Ltd.’s Moving Average
Euroseas Ltd.’s worth is way above its 50-day moving average of $5.01 and way higher than its 200-day moving average of $3.24.
